Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

NHS: Drugs

Department of Health and Social Care written question – answered on 27th April 2020.

Alert me about debates like this

Photo of Crispin Blunt Crispin Blunt Conservative, Reigate

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the NHS Commercial Framework on access to medicines through managed access agreements.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

NHS England and NHS Improvement has advised that the Commercial Framework for new medicines remains in draft at this time with publication expected in spring 2020. The Commercial Framework is designed to complement the processes and methods of the National Institute for Health and Care Excellence’s technology appraisal programme which provides direction on when managed access agreements may be appropriate. The framework will promote the opportunities that currently exist and clarify NHS England and NHS Improvement’s involvement within the existing arrangements rather than advising on new opportunities for managed access agreements.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.